MERCATELLI, Daniela
MERCATELLI, Daniela
Dipartimento di Neuroscienze e Riabilitazione
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
2017 Longo, Francesco; Mercatelli, Daniela; Novello, Salvatore; Arcuri, Ludovico; Brugnoli, Alberto; Vincenzi, Fabrizio; Russo, Isabella; Berti, Giulia; Mabrouk, Omar Sharif; Kennedy, Robert T; Shimshek, Derya R; Varani, Katia; Bubacco, Luigi; Greggio, Elisa; Morari, Michele
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
2018 Arcuri, Ludovico; Novello, Salvatore; Frassineti, Martina; Mercatelli, Daniela; Pisano', Clarissa Anna; Morella, Ilaria; Fasano, Stefania; Journigan, Blair V; Meyer, Michael E; Polgar, Willma E; Brambilla, Riccardo; Zaveri, Nurulain T; Morari, Michele
AT-1001: A high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology
file con accesso da definire2015 Cippitelli, Andrea; Wu, Jinhua; Gaiolini, Kelly A.; Mercatelli, Daniela; Schoch, Jennifer; Gorman, Michelle; Ramirez, Alejandra; Ciccocioppo, Roberto; Khroyan, Taline V.; Yasuda, Dennis; Zaveri, Nurulain T.; Pascual, Conrado; Xie, Xinmin; Toll, Lawrence
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo
2021 Albanese, F.; Mercatelli, D.; Finetti, L.; Lamonaca, G.; Pizzi, S.; Shimshek, D. R.; Bernacchia, G.; Morari, M.
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model
2022 Presotto, L; Bettinardi, V; Mercatelli, D; Picchio, M; Morari, M; Moresco, R M; Belloli, Sara
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models
2020 Kamakolanu, U. G.; Meyer, M. E.; Yasuda, D.; Polgar, W. E.; Marti, M.; Mercatelli, D.; Pisano, C. A.; Brugnoli, A.; Morari, M.; Zaveri, N. T.
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice
2022 Domenicale, Chiara; Mercatelli, Daniela; Albanese, Federica; Novello, Salvatore; Vincenzi, Fabrizio; Varani, Katia; Morari, Michele
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse
2021 Regoni, M.; Zanetti, L.; Comai, S.; Mercatelli, D.; Novello, S.; Albanese, F.; Croci, L.; Consalez, G. G.; Ciammola, A.; Valtorta, F.; Morari, M.; Sassone, J.
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity
2015 Paolone, Giovanna; Brugnoli, Alberto; Arcuri, Ludovico; Mercatelli, Daniela; Morari, Michele
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
2019 Mazzocchi, M.; Wyatt, S. L.; Mercatelli, D.; Morari, M.; Morales-Prieto, N.; Collins, L. M.; Sullivan, A. M.; O'Keeffe, G. W.
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
2022 Novello, S.; Mercatelli, D.; Albanese, F.; Domenicale, C.; Brugnoli, A.; D'Aversa, E.; Vantaggiato, S.; Dovero, S.; Murtaj, V.; Presotto, L.; Borgatti, M.; Shimshek, D. R.; Bezard, E.; Moresco, R. M.; Belloli, S.; Morari, M.
Knock-in mice with NOP-eGFP receptors identify receptor cellular and regional localization
file con accesso da definire2015 Ozawa, Akihiko; Brunori, Gloria; Mercatelli, Daniela; Wu, Jinhua; Cippitelli, Andrea; Zou, Bende; Xie, Xinmin Simon; Williams, Melissa; Zaveri, Nurulain T.; Low, Sarah; Scherrer, Grégory; Kieffer, Brigitte L.; Toll, Lawrence
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
2019 Mercatelli, D.; Bolognesi, P.; Frassineti, M.; Pisano, C. A.; Longo, F.; Shimshek, D. R.; Morari, M.
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
2018 Russo, Isabella; Di Benedetto, Giulietta; Kaganovich, Alice; Ding, Jinhui; Mercatelli, Daniela; Morari, Michele; Cookson, Mark R.; Bubacco, Luigi; Greggio, Elisa
Managing Parkinson's disease: moving ON with NOP
2020 Mercatelli, Daniela; Bezard, Erwan; Eleopra, Roberto; Zaveri, Nurulain T; Morari, Michele
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives
file con accesso da definire2019 Morari, M.; Mercatelli, D.; Brugnoli, A.; Celeghini, C.; Pisanò, Ca
Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells
file con accesso da definire2013 Caputi, Francesca Felicia; Lattanzio, Francesca; Carretta, Donatella; Mercatelli, Daniela; Candeletti, Sanzio; Romualdi, Patrizia
N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain
file con accesso da definire2017 Palmisano, M; Mercatelli, Daniela; Caputi, F. F; Carretta, D; Romualdi, P; Candeletti, S.
NOP receptor ligands and Parkinson’s disease
2019 Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M.
Parkinson's disease: no NOP, new hope
file con accesso da definire2017 Arcuri, Ludovico; Mercatelli, Daniela; Morari, Michele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice | 2017 | Longo, Francesco; Mercatelli, Daniela; Novello, Salvatore; Arcuri, Ludovico; Brugnoli, Alberto; V...incenzi, Fabrizio; Russo, Isabella; Berti, Giulia; Mabrouk, Omar Sharif; Kennedy, Robert T; Shimshek, Derya R; Varani, Katia; Bubacco, Luigi; Greggio, Elisa; Morari, Michele | |
| Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists | 2018 | Arcuri, Ludovico; Novello, Salvatore; Frassineti, Martina; Mercatelli, Daniela; Pisano', Clarissa... Anna; Morella, Ilaria; Fasano, Stefania; Journigan, Blair V; Meyer, Michael E; Polgar, Willma E; Brambilla, Riccardo; Zaveri, Nurulain T; Morari, Michele | |
| AT-1001: A high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology | 2015 | Cippitelli, Andrea; Wu, Jinhua; Gaiolini, Kelly A.; Mercatelli, Daniela; Schoch, Jennifer; Gorman..., Michelle; Ramirez, Alejandra; Ciccocioppo, Roberto; Khroyan, Taline V.; Yasuda, Dennis; Zaveri, Nurulain T.; Pascual, Conrado; Xie, Xinmin; Toll, Lawrence | file con accesso da definire |
| Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo | 2021 | Albanese, F.; Mercatelli, D.; Finetti, L.; Lamonaca, G.; Pizzi, S.; Shimshek, D. R.; Bernacchia, ...G.; Morari, M. | |
| Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model | 2022 | Presotto, L; Bettinardi, V; Mercatelli, D; Picchio, M; Morari, M; Moresco, R M; Belloli, Sara | |
| Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models | 2020 | Kamakolanu, U. G.; Meyer, M. E.; Yasuda, D.; Polgar, W. E.; Marti, M.; Mercatelli, D.; Pisano, C.... A.; Brugnoli, A.; Morari, M.; Zaveri, N. T. | |
| Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice | 2022 | Domenicale, Chiara; Mercatelli, Daniela; Albanese, Federica; Novello, Salvatore; Vincenzi, Fabriz...io; Varani, Katia; Morari, Michele | |
| Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse | 2021 | Regoni, M.; Zanetti, L.; Comai, S.; Mercatelli, D.; Novello, S.; Albanese, F.; Croci, L.; Consale...z, G. G.; Ciammola, A.; Valtorta, F.; Morari, M.; Sassone, J. | |
| Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity | 2015 | Paolone, Giovanna; Brugnoli, Alberto; Arcuri, Ludovico; Mercatelli, Daniela; Morari, Michele | |
| Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling | 2019 | Mazzocchi, M.; Wyatt, S. L.; Mercatelli, D.; Morari, M.; Morales-Prieto, N.; Collins, L. M.; Sull...ivan, A. M.; O'Keeffe, G. W. | |
| In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity | 2022 | Novello, S.; Mercatelli, D.; Albanese, F.; Domenicale, C.; Brugnoli, A.; D'Aversa, E.; Vantaggiat...o, S.; Dovero, S.; Murtaj, V.; Presotto, L.; Borgatti, M.; Shimshek, D. R.; Bezard, E.; Moresco, R. M.; Belloli, S.; Morari, M. | |
| Knock-in mice with NOP-eGFP receptors identify receptor cellular and regional localization | 2015 | Ozawa, Akihiko; Brunori, Gloria; Mercatelli, Daniela; Wu, Jinhua; Cippitelli, Andrea; Zou, Bende;... Xie, Xinmin Simon; Williams, Melissa; Zaveri, Nurulain T.; Low, Sarah; Scherrer, Grégory; Kieffer, Brigitte L.; Toll, Lawrence | file con accesso da definire |
| Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes | 2019 | Mercatelli, D.; Bolognesi, P.; Frassineti, M.; Pisano, C. A.; Longo, F.; Shimshek, D. R.; Morari, M. | |
| Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4 | 2018 | Russo, Isabella; Di Benedetto, Giulietta; Kaganovich, Alice; Ding, Jinhui; Mercatelli, Daniela; M...orari, Michele; Cookson, Mark R.; Bubacco, Luigi; Greggio, Elisa | |
| Managing Parkinson's disease: moving ON with NOP | 2020 | Mercatelli, Daniela; Bezard, Erwan; Eleopra, Roberto; Zaveri, Nurulain T; Morari, Michele | |
| Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives | 2019 | Morari, M.; Mercatelli, D.; Brugnoli, A.; Celeghini, C.; Pisanò, Ca | file con accesso da definire |
| Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells | 2013 | Caputi, Francesca Felicia; Lattanzio, Francesca; Carretta, Donatella; Mercatelli, Daniela; Candel...etti, Sanzio; Romualdi, Patrizia | file con accesso da definire |
| N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain | 2017 | Palmisano, M; Mercatelli, Daniela; Caputi, F. F; Carretta, D; Romualdi, P; Candeletti, S. | file con accesso da definire |
| NOP receptor ligands and Parkinson’s disease | 2019 | Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M. | |
| Parkinson's disease: no NOP, new hope | 2017 | Arcuri, Ludovico; Mercatelli, Daniela; Morari, Michele | file con accesso da definire |